Rheumatoid arthritis trials recruiting in Illinois

All Rheumatoid arthritis trials nationally

Cities in Illinois

Recruiting trials in Illinois

• A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
  NCT07123038 · Phase: Not specified · Ages: 18 Years to 71 Years · Sex: All (male and female) · Illinois: Chicago
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• A Study of AZD0120 in Autoimmune Diseases
  NCT07295847 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
  NCT07607964 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Orland Park
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
  NCT06977724 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Orland Park
• A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
  NCT07137598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Willowbrook
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago, Libertyville, Orland Park, Skokie
• A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
  NCT07276581 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Skokie, Willowbrook
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Willowbrook
• Exactech Shoulder Post Market Clinical Follow-up Study
  NCT05603728 · Phase: Not specified · Ages: 21 Years and older · Sex: All (male and female) · Illinois: Rockford, Schaumburg
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · Illinois: Chicago
• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
  NCT07404865 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago, Schaumburg, Willowbrook
• Physica System Total Knee Replacement Registry Study
  NCT03048201 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Illinois: Aurora
• Probiotics in Adults With Rheumatoid Arthritis
  NCT07304505 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• Study of GS-0151 in Participants With Rheumatoid Arthritis
  NCT06902519 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Illinois: Chicago
• Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
  NCT06201416 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Illinois: Chicago
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Chicago
• The Myelin Disorders Biorepository Project
  NCT03047369 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Illinois: Chicago
• Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
  NCT07621809 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Illinois: Willowbrook